Alvogen Strikes Deals For Pfenex’ Teriparatide
Meanwhile, Pfenex Reports Positive Results In US Equivalence Study
Alvogen has signed marketing deals with local firms in Canada, Israel and South Korea for the teriparatide drug it has licensed from Pfenex. In the US, Pfenex has just completed a human factors study it feels should support a therapeutic equivalence rating for its Forteo rival.
